Horizon Therapeutics Public Limited (HZNP) Return on Equity ROE from the second quarter 2023 to second quarter 2022 and annually, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Horizon Therapeutics Public Limited Company  (NASDAQ: HZNP)

Horizon Therapeutics Public Limited's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Horizon Therapeutics Public Limited in the second quarter 2023?
Horizon Therapeutics Public Limited Company achieved a return on average equity (ROE) of 8.54 % in its second quarter 2023, this is above HZNP's average return on equity of -37.71%.
Horizon Therapeutics Public Limited Companys equity during the 12 months ending in the second quarter 2023 are valued at $5 billion

ROE has advanced compared to 7.38% in the first quarter 2023, due to net income growth.

Within the Major Pharmaceutical Preparations industry 45 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1607, from total ROE ranking in the first quarter 2023 at 1690.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Equity Change 7.39 % 5.76 % 8.56 % 13.11 % -
Y / Y Net Income Change 108.4 % -73.23 % -30.47 % -58.4 % -61.44 %
Net Income (TTM) in Millions 438 372 521 574 765
Return On Equity (TTM) 8.54 % 7.38 % 10.5 % 11.8 % 16.2 %
HZNP's Total Ranking # 1607 # 1690 # 1510 # 1267 # 1088
Equity (TTM) in Millions 5,311 5,096 5,072 5,034 4,946
Seq. Equity Change 4.23 % 0.46 % 0.76 % 1.78 % 2.65 %
Seq. Net Income Change 132.37 % -54.58 % -11.36 % 122.78 % -70.15 %

Back to HZNP Management Effectiveness >> HZNP's 5 Years Annual ROE >> Compare HZNP ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 46
Sector # 123
Overall # 1607

Return On Equity Statistics
High Average Low
33.88 %
-37.71 %
-465.35 %
(Dec 31 2019)   (Sep 30 2014)





HZNP Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 5,072 4,672 4,025 2,185 1,054
Y / Y Equity Change 8.56 % 16.07 % 84.19 % 107.32 % 6.36 %
Net Income in Millions 521 534 390 573 -74
Y / Y Net Income Change -2.43 % 37.12 % -31.98 % - -
Return On Equity 10.28 % 11.44 % 9.68 % 26.22 % -7.04 %

Back to HZNP Management Effectiveness >> HZNP's 5 Years Annual ROE >> Compare HZNP ROE to its Competitors




Annual Roe Comment
In 2022 ROE decreased compared to the previous year to 10.28 %, due to deterioration of net income.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HZNP's' Return on Equity at Yahoo Finance
HZNP's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HZNP's Competitors
Subscribers only: Roe for Horizon Therapeutics Public Limited's Suppliers
Subscribers only: Return On Equity for HZNP's Customers




Companies with similar Return On Equity at Jun 30 2023, within Healthcare Sector ROE
Viskase Holdings inc   23.34 %
Point Biopharma Global Inc   22.69 %
Edwards Lifesciences Corporation  22.63 %
Encompass Health Corporation  22.19 %
Pfizer Inc  22.11 %
Iradimed Corporation  21.22 %
Agilent Technologies inc   20.65 %
Ufp Technologies Inc   20.45 %
Dynavax Technologies Corporation  19.86 %
Maravai Lifesciences Holdings Inc   19.61 %
Biogen Inc   19.60 %
Corcept Therapeutics Inc  19.57 %
Patterson Companies Inc   19.52 %
West Pharmaceutical Services Inc   19.43 %
Iqvia Holdings Inc   18.86 %
Amphastar Pharmaceuticals Inc   18.78 %
Regeneron Pharmaceuticals Inc   18.77 %
Ensign Group Inc  18.73 %
Siga Technologies Inc  18.07 %
Select Medical Holdings Corp  18.03 %
Cadre Holdings inc   17.57 %
United Therapeutics Corporation  17.52 %
Johnson and Johnson  17.48 %
Option Care Health Inc   17.30 %
Haemonetics Corporation  17.28 %
Dexcom Inc   17.25 %
Charles River Laboratories International inc   16.36 %
Stryker Corp  16.09 %
Elite Pharmaceuticals Inc   15.78 %
Bio techne Corp  15.62 %

Date modified: 2026-09-12T06:14:33+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.